Friday, May 8, 2026

A new report from the Advisory Board identifies gaps between payer clinical criteria and evolving medical standards as a primary driver of claim denials. Payers frequently use proprietary or outdated clinical guidelines to justify denials for advanced diagnostics, specialty drugs, and new treatment protocols. The analysis shows these denials are concentrated in oncology, cardiology, and endocrinology, particularly for GLP-1 agonists and next-generation cancer therapies. Billing teams should proactively gather and attach published clinical literature or society guidelines to prior authorization requests and appeals to bridge this evidence gap. Monitor payer policy updates for these high-denial service lines.

MedLearn Publishing has outlined the proposed Evaluation and Management coding changes set for 2027. The updates focus on refining medical decision-making descriptors and time thresholds established in the 2021 overhaul. The goal is to reduce documentation burden while improving accuracy in leveling. Specific revisions to the criteria for 'moderate' and 'high' complexity visits are expected. CMS will finalize the rule later this year. Billing and clinical staff should review the published details now to plan for necessary workflow and EHR template updates before the January 2027 implementation.

The Centers for Medicare & Medicaid Services is considering a policy to automatically enroll seniors into Medicare Advantage plans. The proposal would shift the default enrollment from traditional Medicare to MA for beneficiaries who do not make an active plan selection during their initial enrollment period. CMS is soliciting feedback on the concept, which aims to simplify enrollment but raises concerns about beneficiary choice and plan adequacy. If implemented, this could accelerate the shift of beneficiaries from fee-for-service Medicare to managed care, affecting provider referral patterns and network contracts. The policy discussion is part of broader CMS efforts to increase MA penetration, which already covers more than half of Medicare beneficiaries. Monitor CMS announcements for a formal proposal and comment period.

Blue Cross Blue Shield of Michigan initially denied a $76,000 kidney transplant procedure for a patient at Michigan Medicine, then reversed the decision after the Detroit Free Press inquired about the case. The denial was based on the insurer's determination that the procedure was not medically necessary, despite the patient's physician's recommendation. The reversal highlights the opaque and often inconsistent nature of medical necessity reviews, particularly for high-cost procedures. For practices, it underscores the reality that payer denials for major interventions can sometimes be overturned with persistent advocacy and external pressure, but the process remains adversarial and time-consuming. The case adds to the national narrative of prior authorization and denial practices delaying care.